Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)

CUSIP: 29405E208

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
1,022,530
Total 13F shares
1,252,390
Share change
+1,252,390
Total reported value
$268,000
Price per share
$0.21
Number of holders
1
Value change
+$268,000
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 29405E208?
CUSIP 29405E208 identifies ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Hudson Bay Capital Management LP
13F
Company
class O/S missing
4,774,900
$1,576,000 31 Mar 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
class O/S missing
1,990,600
$657,000 31 Mar 2022
13F
AdvisorShares Investments LLC
13F
Company
class O/S missing
922,371
$304,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
760,589
$251,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
class O/S missing
499,038
$165,000 31 Mar 2022
13F
Ikarian Capital, LLC
13F
Company
class O/S missing
423,834
$141,000 31 Mar 2022
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
class O/S missing
286,267
$94,000 31 Mar 2022
13F
Virtu Financial LLC
13F
Company
class O/S missing
276,184
$91,000 31 Mar 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
176,363
$58,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
166,537
$54,000 31 Mar 2022
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
class O/S missing
107,500
$35,000 31 Mar 2022
13F
UBS Group AG
13F
Company
class O/S missing
97,427
$32,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
class O/S missing
90,634
$30,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
58,332
$20,000 31 Mar 2022
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
52,283
$17,000 31 Mar 2022
13F
Warberg Asset Management LLC
13F
Company
class O/S missing
45,000
$15,000 31 Mar 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
class O/S missing
44,160
$15,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
36,490
$12,000 31 Mar 2022
13F
SCOTIA CAPITAL INC.
13F
Company
class O/S missing
27,272
$9,000 31 Mar 2022
13F
Engineers Gate Manager LP
13F
Company
class O/S missing
25,824
$9,000 31 Mar 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
20,314
$7,000 31 Mar 2022
13F
Creative Planning
13F
Company
class O/S missing
17,577
$6,000 31 Mar 2022
13F
CITIGROUP INC
13F
Company
class O/S missing
16,765
$6,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
11,419
$4,000 31 Mar 2022
13F
Integrated Wealth Concepts LLC
13F
Company
class O/S missing
10,801
$4,000 31 Mar 2022
13F
Cutler Group LLC / CA
13F
Company
class O/S missing
5,600
$1,000 31 Mar 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
4,000
$1,000 31 Mar 2022
13F
Carter Julian Ward
3/4/5
Chief Financial Officer
class O/S missing
744,429
19 Jan 2022
Thompson Bradley George
3/4/5
Director
class O/S missing
53,160
16 Sep 2021

Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q2 2022

As of 30 Jun 2022, Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 1,252,390 shares. The largest 1 holders included AdvisorShares Investments LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q4 2024 Across Filers

Q4 2024 holders
18
Q2 2022 holders
1
Holder diff
-17
Investor Q4 2024 Shares Q2 2022 Shares Share Diff Share Chg % Q4 2024 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .